The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

[1]  R. Gibbons,et al.  Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents. , 2020, Journal of the American Academy of Child and Adolescent Psychiatry.

[2]  Yi Hui Liu,et al.  Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder. , 2020, Journal of developmental and behavioral pediatrics : JDBP.

[3]  S. Faraone,et al.  A literature review and meta-analysis on the effects of ADHD medications on functional outcomes. , 2020, Journal of psychiatric research.

[4]  T. Banaschewski,et al.  Individualised stepwise adaptive treatment for 3–6-year-old preschool children impaired by attention-deficit/hyperactivity disorder (ESCApreschool): study protocol of an adaptive intervention study including two randomised controlled trials within the consortium ESCAlife , 2020, Trials.

[5]  P. Tymms,et al.  Academic Outcomes Following a School-Based RCT for ADHD: 6-Year Follow-Up , 2020, Journal of attention disorders.

[6]  B. D’Onofrio,et al.  Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders. , 2019, Journal of child psychology and psychiatry, and allied disciplines.

[7]  Christoph U. Lehmann,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents , 2019, Pediatrics.

[8]  D. Coghill.  Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (For). , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  B. D’Onofrio,et al.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases , 2019, Biological Psychiatry.

[10]  Greta M. Massetti,et al.  Randomized Trial of First-Line Behavioral Intervention to Reduce Need for Medication in Children with ADHD , 2019, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[11]  C. Freitag,et al.  Slow cortical potentials neurofeedback in children with ADHD: comorbidity, self-regulation and clinical outcomes 6 months after treatment in a multicenter randomized controlled trial , 2019, European Child & Adolescent Psychiatry.

[12]  T. Ford,et al.  Transition between child and adult services for young people with attention-deficit hyperactivity disorder (ADHD): findings from a British national surveillance study , 2019, The British Journal of Psychiatry.

[13]  J. Buitelaar,et al.  Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials. , 2019, The lancet. Psychiatry.

[14]  J. Buitelaar,et al.  Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study. , 2019, The American journal of psychiatry.

[15]  A. Cipriani,et al.  Combining Pharmacological and Nonpharmacological Interventions in Network Meta-analysis in Psychiatry. , 2019, JAMA psychiatry.

[16]  W. van den Brink,et al.  Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial. , 2019, Drug and alcohol dependence.

[17]  H. Steinhausen,et al.  Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study. , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

[18]  Catarina Almqvist,et al.  Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication. , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

[19]  C. Hartman,et al.  Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis , 2019, European Psychiatry.

[20]  Frances L. Doyle,et al.  A national child mental health literacy initiative is needed to reduce childhood mental health disorders , 2019, The Australian and New Zealand journal of psychiatry.

[21]  M. Akmatov,et al.  Trends and regional variations in the administrative prevalence of attention-deficit/hyperactivity disorder among children and adolescents in Germany , 2018, Scientific Reports.

[22]  C. Flückiger,et al.  Adverse effects of psychotherapy: protocol for a systematic review and meta-analysis , 2018, Systematic Reviews.

[23]  S. Faraone,et al.  Association between attention deficit hyperactivity disorder and asthma: a systematic review and meta-analysis and a Swedish population-based study. , 2018, The lancet. Psychiatry.

[24]  F. Shokraneh,et al.  Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis , 2018, The lancet. Psychiatry.

[25]  Sally Hopewell,et al.  Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension , 2018, Trials.

[26]  J. Swanson,et al.  Treatment strategies for ADHD: an evidence-based guide to select optimal treatment , 2018, Molecular Psychiatry.

[27]  Alan E Kazdin,et al.  Annual Research Review: Expanding mental health services through novel models of intervention delivery. , 2018, Journal of child psychology and psychiatry, and allied disciplines.

[28]  A. Thapar,et al.  Conduct disorder in ADHD , 2018, Oxford Medicine Online.

[29]  D. Coghill,et al.  Quality of life and impairment in ADHD , 2018, Oxford Medicine Online.

[30]  D. Coghill,et al.  Organizing and delivering treatment for ADHD , 2018, Oxford Medicine Online.

[31]  S. Hinshaw,et al.  ADHD in the twenty-first century , 2018, Oxford Medicine Online.

[32]  J. Biederman,et al.  ADHD and substance misuse , 2018, Oxford Medicine Online.

[33]  E. Simonoff.  Intellectual impairment and neurogenetic disorders , 2018, Oxford Medicine Online.

[34]  A. Fallgatter,et al.  ESCAlate – Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial , 2018, Trials.

[35]  E. Luis,et al.  Risk of poisoning in children and adolescents with ADHD: a systematic review and meta-analysis , 2018, Scientific Reports.

[36]  M. Danckaerts,et al.  Oxford Textbook of Attention Deficit Hyperactivity Disorder , 2018, Oxford Medicine Online.

[37]  T. Banaschewski,et al.  Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)—Study protocol of a randomised controlled trial within the consortium ESCAlife , 2018, Trials.

[38]  A. Chacko,et al.  Bending the Curve: A Community-Based Behavioral Parent Training Model to Address ADHD-Related Concerns in the Voluntary Sector in Denmark , 2017, Journal of Abnormal Child Psychology.

[39]  A. Chacko,et al.  Adverse Events in Behavioral Parent Training for Children with ADHD: An Under-Appreciated Phenomenon , 2018 .

[40]  David Coghill,et al.  ADHD in children and young people: prevalence, care pathways, and service provision. , 2017, The lancet. Psychiatry.

[41]  Kenneth K C Man,et al.  Association of Risk of Suicide Attempts With Methylphenidate Treatment , 2017, JAMA psychiatry.

[42]  P. Chokka,et al.  Adult ADHD and comorbid disorders: clinical implications of a dimensional approach , 2017, BMC Psychiatry.

[43]  A. Sjölander,et al.  Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder , 2017, JAMA psychiatry.

[44]  T. Banaschewski,et al.  ESCAschool study: trial protocol of an adaptive treatment approach for school-age children with ADHD including two randomised trials , 2017, BMC Psychiatry.

[45]  S. Dalsgaard,et al.  Teenage Parenthood and Birth Rates for Individuals With and Without Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study. , 2017, Journal of the American Academy of Child and Adolescent Psychiatry.

[46]  A. Sjölander,et al.  ADHD Medication and Substance-Related Problems. , 2017, The American journal of psychiatry.

[47]  A. Sjölander,et al.  Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes , 2017, JAMA psychiatry.

[48]  C. Whittington,et al.  Annual Research Review: Digital health interventions for children and young people with mental health problems – a systematic and meta‐review , 2017, Journal of child psychology and psychiatry, and allied disciplines.

[49]  C. Freitag,et al.  Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects , 2017, Front. Hum. Neurosci..

[50]  L. Rohde,et al.  What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder? , 2017, ADHD Attention Deficit and Hyperactivity Disorders.

[51]  Alan M. Zaslavsky,et al.  The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys , 2017, ADHD Attention Deficit and Hyperactivity Disorders.

[52]  Jürgen Unützer,et al.  A Tipping Point for Measurement-Based Care. , 2017, Psychiatric services.

[53]  P. Lichtenstein,et al.  Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study , 2016, Biological Psychiatry.

[54]  E. Sonuga-Barke.  Can Medication Effects Be Determined Using National Registry Data? A Cautionary Reflection on Risk of Bias in “Big Data” Analytics , 2016, Biological Psychiatry.

[55]  D. Brandeis,et al.  The European ADHD Guidelines Group replies. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[56]  J. Micoulaud-Franchi,et al.  Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Efficacy. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[57]  J. Lubar,et al.  Neurofeedback in Attention-Deficit/Hyperactivity Disorder: Evaluation Difficulties. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[58]  P. Lichtenstein,et al.  Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release. , 2016, JAMA.

[59]  T. Banaschewski,et al.  Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system , 2016, Translational psychiatry.

[60]  T. Moffitt,et al.  Life Span Studies of ADHD—Conceptual Challenges and Predictors of Persistence and Outcome , 2016, Current Psychiatry Reports.

[61]  Kristian Thorlund,et al.  Use of network meta-analysis in clinical guidelines , 2016, Bulletin of the World Health Organization.

[62]  V. Harpin,et al.  Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study. , 2016, Journal of child psychology and psychiatry, and allied disciplines.

[63]  Jim Stevenson,et al.  Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[64]  Inbal Nahum-Shani,et al.  Treatment Sequencing for Childhood ADHD: A Multiple-Randomization Study of Adaptive Medication and Behavioral Interventions , 2016, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[65]  W. Kronenberger,et al.  Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges , 2016, Neuropsychiatric disease and treatment.

[66]  E. Simonsen,et al.  Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials , 2015, BMJ : British Medical Journal.

[67]  D. Coghill,et al.  Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway , 2015, Child and Adolescent Psychiatry and Mental Health.

[68]  S. Dalsgaard,et al.  Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study. , 2015, The lancet. Psychiatry.

[69]  Stuart Logan,et al.  Non-pharmacological interventions for attention-deficit/hyperactivity disorder (ADHD) delivered in school settings: systematic reviews of quantitative and qualitative research. , 2015, Health technology assessment.

[70]  D. Coghill,et al.  Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes , 2015, Expert review of clinical pharmacology.

[71]  D. Coghill,et al.  Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls , 2015, European Child & Adolescent Psychiatry.

[72]  R. Mikolajczyk,et al.  Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study. , 2015, JAMA pediatrics.

[73]  K. Myers,et al.  Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial. , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

[74]  J. Buitelaar,et al.  Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

[75]  D. Moher,et al.  The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials , 2015, Systematic Reviews.

[76]  Justine Schneider,et al.  Practitioner Review: Pathways to care for ADHD – a systematic review of barriers and facilitators , 2015, Journal of child psychology and psychiatry, and allied disciplines.

[77]  C. Cunningham,et al.  Systematic Review of Patients’ and Parents’ Preferences for ADHD Treatment Options and Processes of Care , 2015, The Patient - Patient-Centered Outcomes Research.

[78]  V. Roessner,et al.  Trends in psychopharmacologic treatment of tic disorders in children and adolescents in Germany , 2015, European Child & Adolescent Psychiatry.

[79]  Jeffrey M. Halperin,et al.  Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Irritability: Results From the Multimodal Treatment Study of Children With ADHD (MTA) , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

[80]  Kenneth K C Man,et al.  Methylphenidate and the Risk of Trauma , 2015, Pediatrics.

[81]  Jonathan Posner,et al.  Using Stimulants to Treat ADHD-Related Emotional Lability , 2014, Current Psychiatry Reports.

[82]  Marina Danckaerts,et al.  Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[83]  A. Sjölander,et al.  Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study , 2014, BMJ : British Medical Journal.

[84]  T. Banaschewski,et al.  Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder: randomized-withdrawal study design. , 2014, Journal of the American Academy of Child and Adolescent Psychiatry.

[85]  J. Buitelaar,et al.  Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[86]  S. Young,et al.  A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations , 2014, Psychological Medicine.

[87]  A. Sjölander,et al.  Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. , 2014, JAMA psychiatry.

[88]  L. Rohde,et al.  Prevalence of obesity in attention-deficit/hyperactivity disorder: study protocol for a systematic review and meta-analysis , 2014, BMJ Open.

[89]  H. Steinhausen,et al.  Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample , 2014, European Neuropsychopharmacology.

[90]  D. Coghill,et al.  The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010) , 2013, Child and Adolescent Psychiatry and Mental Health.

[91]  K. Matthews,et al.  A longitudinal examination of neuropsychological and clinical functioning in boys with attention deficit hyperactivity disorder (ADHD): improvements in executive functioning do not explain clinical improvement , 2013, Psychological Medicine.

[92]  M. Arns,et al.  Evidence for efficacy of neurofeedback in ADHD? , 2013, The American journal of psychiatry.

[93]  D. Brandeis,et al.  Response to Chronis-Tuscano et al. and Arns and Strehl. , 2013, The American journal of psychiatry.

[94]  David Coghill,et al.  Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. , 2013, The American journal of psychiatry.

[95]  J. Buitelaar,et al.  Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[96]  A. Sjölander,et al.  Medication for attention deficit-hyperactivity disorder and criminality. , 2012, The New England journal of medicine.

[97]  Sudha R. Raman,et al.  Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design , 2012, Injury Prevention.

[98]  Ö. Özcan,et al.  Paediatric trauma patients and attention deficit hyperactivity disorder: correlation and significance , 2012, Emergency Medicine Journal.

[99]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[100]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[101]  E. Taylor,et al.  Child and caregiver issues in the treatment of attention deficit–hyperactivity disorder: education, adherence and treatment choice , 2011 .

[102]  Michelle E. Kho,et al.  AGREE II: advancing guideline development, reporting and evaluation in health care , 2010, Canadian Medical Association Journal.

[103]  Michael Fitzgerald,et al.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD , 2010, BMC psychiatry.

[104]  Harriet Stewart.  Developing Mental Health Services for Children and Adolescents with Learning Disabilities: A Toolkit for Clinicians , 2010 .

[105]  S. Pliszka.  The MTA at 8. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[106]  P. Emmelkamp,et al.  Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. , 2008, Clinical psychology review.

[107]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[108]  S. Cortese,et al.  Sleep problems associated with ADHD: a review of current therapeutic options and recommendations for the future , 2007, Expert review of neurotherapeutics.

[109]  S. Hinshaw.  Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. , 2007, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

[110]  B. Horta,et al.  The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.

[111]  J. Buitelaar,et al.  A Randomized, Double-Blind Study of Continuation Treatment for Attention-Deficit/Hyperactivity Disorder After 1 Year , 2007, Biological Psychiatry.

[112]  J. Johnston,et al.  Functional and psychosocial impairment in adults with undiagnosed ADHD , 2006, Psychological Medicine.

[113]  A. Philipsen.  Differential diagnosis and comorbidity of attention-deficit/hyperactivity disorder (ADHD) and borderline personality disorder (BPD) in adults , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[114]  W. Kim,et al.  Child and Adolescent Psychiatry Workforce: A Critical Shortage and National Challenge , 2003, Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry.

[115]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[116]  J. Swanson.  Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (Against). , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

[117]  J. Swanson,et al.  Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long-Term? , 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

[118]  Clarissa Tochetto de Oliveira.  Psychoeducation for Attention De fi cit / Hyperactivity Disorder : What , How and Who Shall We Inform ? , 2018 .

[119]  Alan E Kazdin,et al.  Addressing the treatment gap: A key challenge for extending evidence-based psychosocial interventions. , 2017, Behaviour research and therapy.

[120]  C. Whittington,et al.  Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis. , 2016, Health technology assessment.

[121]  D. Cohen.  Medication for attention deficit-hyperactivity disorder and criminality. , 2013, The New England journal of medicine.

[122]  G. DuPaul,et al.  TREATMENT OF ADHD IN SCHOOL SETTINGS , 2009 .

[123]  R. Barkley,et al.  The adolescent outcome of hyperactive children diagnosed by research criteria--III. Mother-child interactions, family conflicts and maternal psychopathology. , 1991, Journal of child psychology and psychiatry, and allied disciplines.